IMCR

IMMUNOCORE HLDGS PLC

IMCR·45258D105·US·ADR·Healthcare - Biotechnology-13D/G

IMCR (IMMUNOCORE HLDGS PLC) is held by 81 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($146.8M), FMR LLC ($145.6M), WELLINGTON MANAGEMENT GROUP LLP ($141.9M). Net institutional sentiment: Mixed.

81
Holders
Avg rating(21 Elite)
$976.8M
Total Value
54% (91)
Fund Consensus
43 buying - 37 selling
IMCRSmart Money Verdict
View all
Held by 81 funds
21 elite
Who's Trading
ActivistVPVestal Point Capital, LP5.5%May 15, 2026
ActivistTRT. Rowe Price Investment Management, Inc.3.7%May 15, 2026
InsiderJBJallal BahijaSell $371KFeb 18, 2026
InsiderBMBerman David MSell $193KFeb 18, 2026
InsiderSASt Leger Tina AmberSell $32KFeb 18, 2026
InsiderGJGOLL JOHNSell $23KFeb 18, 2026
InsiderBMBerman David MSell $23KDec 5, 2025
InsiderBMBerman David MSell $1.3MDec 4, 2025
InsiderBMBerman David MSell $221KNov 28, 2025
InsiderBMBerman David MSell $2.8MNov 26, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
4.9M$146.8M1.5%-25.79%
0
Increased
4.8M(+6.4%)$145.6M0.0%+8.81%
32
Increased
4.7M(+0.3%)$141.9M0.0%-37.04%
30
Decreased
3.7M(-6.8%)$111.4M0.1%-3.04%
0
Increased
1.2M(+35.7%)$37.3M0.0%-9.99%
38
Increased
1.1M(+118.6%)$33.2M0.0%+2.63%
47
Increased
1.1M(+3.4%)$32.6M0.1%-37.52%
36
Increased
1M(+184.2%)$30.8M0.0%-4.45%
47
Decreased
919,332(-5.1%)$27.7M0.0%-41.38%
0
Decreased
734,397(-68.4%)$22.1M0.1%-16.94%
0
Increased
661,786(+601.2%)$20M0.1%-1.54%
55
Increased
656,309(+99.4%)$19.8M0.0%+1.33%
46
Increased
633,174(+65.1%)$19.1M0.1%-0.83%
41
Increased
594,712(+30.9%)$17.9M0.0%-5.16%
36
Decreased
519,130(-21.2%)$15.7M0.0%-15.86%
0
Decreased
407,373(-0.0%)$12.3M0.0%-12.69%
0
Increased
335,191(+82.2%)$10.1M0.0%-4.10%
43
Increased
323,606(+12.7%)$9.8M0.0%-2.14%
31
Increased
316,762(+0.0%)$9.6M0.0%-37.49%
28
Unchanged
269,729$8.1M0.0%-19.23%
0

Showing 1-20 of 91

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used